文献速递类风湿关节炎

早期未治疗类风湿关节炎中ACPA精细特异性数量与类型与肺部异常的关联

Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.
PubMed 文献 · RMD Open · 2020-01-01

该研究纳入106例新诊断未治疗类风湿关节炎(RA)患者,行高分辨率CT(HRCT)评估肺部异常,并用CCP2试剂盒或含10种瓜氨酸化肽的免疫芯片检测抗体谱。结果显示,CCP2 IgG、RF IgA及抗瓜氨酸化纤维蛋白原抗体与肺实质异常相关,ACPA精细特异性数量多者肺实质异常风险高;ACPA特异性与气道异常无显著关联。

要点

  • CCP2 IgG、RF IgA和抗瓜氨酸化纤维蛋白原抗体与早期未治疗RA肺实质异常相关。
  • ACPA精细特异性数量越多,RA诊断时肺实质异常风险越高。
  • 未发现ACPA特异性与气道异常风险之间存在显著信号。

核心结论

  • RF和ACPA(尤其抗瓜氨酸化纤维蛋白原肽抗体)阳性及ACPA精细特异性数量多与早期未治疗RA的肺实质异常相关。

研究设计与样本

  • 研究纳入106例新诊断未治疗RA患者,行肺部HRCT检查,用CCP2检测试剂盒或含10种不同瓜氨酸化肽的免疫芯片分析血样中RF和ACPA,采用逻辑回归评估HRCT表现与抗体谱的关联。

主要发现

  • HRCT异常中,肺实质异常58例(54.7%),气道异常68例(64.2%)。
  • CCP2 IgG、RF IgA和抗瓜氨酸化纤维蛋白原抗体与肺实质异常存在关联。
  • ACPA精细特异性数量多与RA诊断时肺实质异常高风险相关。
  • ACPA特异性与气道异常风险之间未发现显著信号。

临床怎么用

  • 对早期未治疗RA患者,检测RF IgA、CCP2 IgG及抗瓜氨酸化纤维蛋白原抗体有助于识别肺实质异常高风险者。
  • ACPA精细特异性数量多的早期RA患者应关注肺实质异常,可考虑HRCT评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rheumatoid arthritis (RA)-associated anticitrullinated protein/peptide antibodies (ACPA) might originate at mucosal sites such as the lungs. We aimed to examine the relationship between the ACPA repertoire and lung abnormalities on high-resolution CT (HRCT) in patients with earlyuntreated RA. METHODS: 106 patients with newly diagnosed untreated RA were examined with HRCT of the lungs. Blood samples were analysed for presence of rheumatoid factor (RF) and ACPA using either a CCP2 detection kit or an immunochip containing 10 different citrullinated peptides. Association between HRCT findings and the antibody repertoire was assessed by logistic regression analysis. RESULTS: The number (%) of patients with HRCT abnormalities was 58 (54.7%) for parenchymal abnormalities and 68 (64.2%) for airway abnormalities. CCP2 IgG, RF IgA and antibodies against citrullinated fibrinogen were associated with the presence of parenchymal lung abnormalities. Interestingly, a high number of ACPA fine specificities gave a high risk of having parenchymal lung abnormalities at the time of RA diagnosis. No significant signals were identified between ACPA specificities and risk for airway abnormalities. CONCLUSIONS: The presence of RF and ACPAs (especially against citrullinated fibrinogen peptides) as well as high number of ACPAs fine specificities are associated with parenchymal lung abnormalities in patients with early, untreated RA. This provides further support for an important pathogenic link between the lung and systemic autoimmunity, contributing to RA development.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Joshua V, Hensvold AH, Reynisdottir G, et al. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis. RMD Open. 2020. PMID: 32917833. doi:10.1136/rmdopen-2020-001278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。